<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2026-293-299</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3949</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Энтезиты при псориатическом артрите: клиническая оценка и взаимосвязь с характеристиками заболевания</article-title><trans-title-group xml:lang="en"><trans-title>Enthesitis in psoriatic arthritis: Clinical assessment and association with disease characteristics</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8874-3663</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сомов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Somov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сомов Дмитрий Вадимович</p><p>117997, Москва, ул. Островитянова, 1; 107076, Москва, ул. Короленко, 3, стр. 6</p></bio><bio xml:lang="en"><p>Dmitrii Somov</p><p>117997, Moscow, Ostrovitianova str., 1; 107076, Moscow, Korolenko str., 3, building 6</p></bio><email xlink:type="simple">somovmd@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5610-4819</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аничков</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Anichkov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>117997, Moscow, Ostrovitianova str., 1</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7410-9784</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клименко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimenko</surname><given-names>A. A</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>117997, Moscow, Ostrovitianova str., 1</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University; State Research Center of Dermatovenereology and Cosmetology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2026</year></pub-date><volume>64</volume><issue>3</issue><fpage>293</fpage><lpage>299</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сомов Д.В., Аничков Д.А., Клименко А.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Сомов Д.В., Аничков Д.А., Клименко А.А.</copyright-holder><copyright-holder xml:lang="en">Somov D.V., Anichkov D.A., Klimenko A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3949">https://rsp.mediar-press.net/rsp/article/view/3949</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Несмотря на внедрение в практику визуализирующих методов для выявления энтезитов (ультразвукового исследования, магнитно-резонансной томографии), клиническая оценка остается основой диагностики и в повседневной практике, и в клинических исследованиях. Однако частота выявления энтезитов у пациентов с псориатическим артритом (ПсА) демонстрирует существенный разброс, что может быть прежде всего связано с различиями в методах оценки.</p><p>Цель исследования – изучить частоту выявления энтезитов у больных псориатическим артритом с применением современных шкал оценки и изучить ее взаимосвязь с характеристиками заболевания.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В одномоментное исследование включены 116 пациентов с ПсА, соответствующих критериям CASPAR (ClASsification for Psoriatic ARthritis). Оценку энтезопатии проводили с помощью индексов LEI (Leeds Enthesitis Index), MASES (Maastricht Ankylosing Spondylitis Enthesitis Score), SPARCC (Spondyloarthritis Research Consortium of Canada) и их сочетания.</p></sec><sec><title>Результаты</title><p>Результаты. У 96 (82,8%) пациентов имелся хотя бы один болезненный энтезис. У 47 (49%) отмечалась болезненность 1–3 энтезисов (у 19,8% – 1 энтезис, у 18,8% – 2 энтезиса, у 10,4% – 3 энтезиса), у остальных – 4 и более. Медиана значений индексов составляла: LEI – 1,0 [0; 2,25]; SPARCC – 3,0 [1,0; 5,25]; MASES – 1,0 [0; 2,0]. Частота энтезитов (хотя бы 1 болезненный энтезис) по данным индексов составила: LEI – 62,5% (n=60), MASES – 63,5% (n=61), SPARCC – 87,5% (n=84). У 9 (9,4%) пациентов по данным индекса MASES был выявлен 1 и более болезненный энтезис, в то время как по SPARCC и LEI не было выявлено ни одного. Наблюдалась положительная корреляция умеренной силы между индексом массы тела (ИМТ) и SPARCC (ρ=0,32; p=0,001). Пациенты с нормальным ИМТ имели меньшее значение числа болезненных энтезисов (медиана – 3 [1; 5] и 4 [2; 10]; p=0,043), индекса SPARCC (2 [1; 3] и 3 [1; 6]; p=0,025) и комбинации индексов SPARCC + MASES (4 [1; 11] и 6,5 [5; 11]; p=0,034).</p></sec><sec><title>Заключение</title><p>Заключение. Энтезиты встречаются у значительной доли пациентов с ПсА (82,8%). С целью повышения частоты их выявления предпочтительно использование комбинации индексов SPARCC и MASES.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Despite the integration of imaging methods such as ultrasound and magnetic resonance imaging for the detection of enthesitis, clinical assessment remains the foundation of diagnosis in both everyday practice and clinical studies. However, the frequency of detecting enthesitis in patients with psoriatic arthritis (PsA) varies considerably, which may be primarily due to differences in assessment methods.</p><p>The aim – to evaluate the frequency of enthesitis in patients with psoriatic arthritis using modern assessment scales and to investigate the association between enthesitis measures and disease characteristics.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. This cross-sectional study included 116 patients with PsA diagnosed according to the CASPAR (ClASsification for Psoriatic ARthritis) criteria. Enthesitis was assessed using the Leeds Enthesitis Index (LEI), the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES), the Spondyloarthritis Research Consortium of Canada Enthesitis Index (SPARCC), and a combination of these indices.</p></sec><sec><title>Results</title><p>Results. A total of 96 (82.8%) patients had at least one tender enthesis. Among these, 47 (49%) patients had tenderness at 1–3 entheses (1 enthesis – 19.8%; 2 entheses – 18.8%; 3 entheses – 10.4%), while the remaining patients had tenderness at 4 or more entheses. The median values of the indices were as follows: LEI – 1.0 [0.0; 2.25], SPARCC – 3.0 [1.0; 5.25], MASES – 1.0 [0.0; 2.0]. The frequency of enthesitis (at least one tender enthesis) according to each index was: LEI – 60 (62.5%) patients, MASES – 61 (63.5%) patients, SPARCC – 84 (87.5%) patients. In 9 (9.4%) patients, MASES identified one or more enthesitis sites, whereas no tender entheses were detected by SPARCC or LEI. A moderate positive correlation was found between body mass index (BMI) and the SPARCC index (ρ=0.32; p=0.001). Patients with normal BMI had lower values for the number of tender entheses (3 [1; 5] vs. 4 [2; 10]; p=0.043), the SPARCC index (2 [1; 3] vs. 3 [1; 6]; p=0.025), and the combined SPARCC + MASES index (4 [1; 11] vs. 6.5 [5; 11]; p=0.034).</p></sec><sec><title>Conclusion</title><p>Conclusion. Enthesitis is present in a significant proportion of patients with PsA (82.1%). To improve the detection rate of enthesitis in patients with PsA, the combined use of the SPARCC and MASES indices is preferable.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>псориатический артрит</kwd><kwd>энтезиты</kwd><kwd>Leeds Enthesitis Index (LEI)</kwd><kwd>the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)</kwd><kwd>the Spondyloarthritis Research Consortium of Canada Enthesitis Index (SPARCC)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>psoriatic arthritis</kwd><kwd>enthesitis</kwd><kwd>Leeds Enthesitis Index (LEI)</kwd><kwd>the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)</kwd><kwd>the Spondyloarthritis Research Consortium of Canada Enthesitis Index (SPARCC)</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Eder L, Mathew AJ, Carron P, Bertheussen H, Cañete JD, Azem M, et al. Management of enthesitis in patients with psoriatic arthritis: An updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol. 2023;50(2):258-264. doi: 10.3899/jrheum.220312</mixed-citation><mixed-citation xml:lang="en">Eder L, Mathew AJ, Carron P, Bertheussen H, Cañete JD, Azem M, et al. Management of enthesitis in patients with psoriatic arthritis: An updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol. 2023;50(2):258-264. doi: 10.3899/jrheum.220312</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-2673. doi: 10.1002/art.21972</mixed-citation><mixed-citation xml:lang="en">Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-2673. doi: 10.1002/art.21972</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76(4):673-680. doi: 10.1136/annrheumdis-2016-210242</mixed-citation><mixed-citation xml:lang="en">Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76(4):673-680. doi: 10.1136/annrheumdis-2016-210242</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yang F, Lu C, Liu H, Dou L, Wang Y, Li H, et al. Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR). Chin Med J (Engl). 2023;136(8):951-958. doi: 10.1097/CM9.0000000000002646</mixed-citation><mixed-citation xml:lang="en">Yang F, Lu C, Liu H, Dou L, Wang Y, Li H, et al. Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR). Chin Med J (Engl). 2023;136(8):951-958. doi: 10.1097/CM9.0000000000002646</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pignon C, Bibas N, Lopez-Medina C, Fautrel B, Gossec L. Clinical enthesitis in patient with psoriatic arthritis, a systematic literature review with metaanalysis. Joint Bone Spine. 2025;92(2):105807. doi: 10.1016/j.jbspin.2024.105807</mixed-citation><mixed-citation xml:lang="en">Pignon C, Bibas N, Lopez-Medina C, Fautrel B, Gossec L. Clinical enthesitis in patient with psoriatic arthritis, a systematic literature review with metaanalysis. Joint Bone Spine. 2025;92(2):105807. doi: 10.1016/j.jbspin.2024.105807</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fredriksson T, Pettersson U: Severe psoriasis: Oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. doi: 10.1159/000250839</mixed-citation><mixed-citation xml:lang="en">Fredriksson T, Pettersson U: Severe psoriasis: Oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. doi: 10.1159/000250839</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol. 1991;124(6):565-570. doi: 10.1111/j.1365-2133.1991.tb04952.x</mixed-citation><mixed-citation xml:lang="en">Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol. 1991;124(6):565-570. doi: 10.1111/j.1365-2133.1991.tb04952.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49(2):206-212. doi: 10.1067/s0190-9622(03)00910-1</mixed-citation><mixed-citation xml:lang="en">Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49(2):206-212. doi: 10.1067/s0190-9622(03)00910-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216. doi: 10.1111/j.1365-2230.1994.tb01167.x</mixed-citation><mixed-citation xml:lang="en">Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216. doi: 10.1111/j.1365-2230.1994.tb01167.x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69(8):1441-1447. doi: 10.1136/ard.2009.122259</mixed-citation><mixed-citation xml:lang="en">Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69(8):1441-1447. doi: 10.1136/ard.2009.122259</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Proft F, Schally J, Brandt HC, Brandt-Juergens J, Burmester GR, Haibel H, et al. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: A prospective multicentre cross-sectional study. RMD Open. 2022;8(2):e002626. doi: 10.1136/rmdopen-2022-002626</mixed-citation><mixed-citation xml:lang="en">Proft F, Schally J, Brandt HC, Brandt-Juergens J, Burmester GR, Haibel H, et al. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: A prospective multicentre cross-sectional study. RMD Open. 2022;8(2):e002626. doi: 10.1136/rmdopen-2022-002626</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59(5):686-691. doi: 10.1002/art.23568</mixed-citation><mixed-citation xml:lang="en">Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59(5):686-691. doi: 10.1002/art.23568</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003;62(2):127-132. doi: 10.1136/ard.62.2.127</mixed-citation><mixed-citation xml:lang="en">Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003;62(2):127-132. doi: 10.1136/ard.62.2.127</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index. Ann Rheum Dis. 2009;68(6):948-953. doi: 10.1136/ard.2007.084244</mixed-citation><mixed-citation xml:lang="en">Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index. Ann Rheum Dis. 2009;68(6):948-953. doi: 10.1136/ard.2007.084244</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Псориаз артропатический. Псориатический артрит. Клинические рекомендации. М.;2024.</mixed-citation><mixed-citation xml:lang="en">Arthropathic psoriasis. Psoriatic arthritis. Clinical guidelines. Moscow;2024 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Дубинина ТВ, Гайдукова ИЗ, Годзенко АА, Лапшина СА, Ребров АП, Румянцева ОА, и др. Рекомендации по оценке активности болезни и функционального состояния больных анкилозирующим спондилитом в клинической практике. Научно-практическая ревматология. 2017;55(4):344-350. doi: 10.14412/1995-4484-2017-344-350</mixed-citation><mixed-citation xml:lang="en">Dubinina TV, Gaidukova IZ, Godzenko AA, Lapshina SA, Rebrov AP, Rumyantseva OA, et al. Guidelines for the assessment of disease activity and functional status in patients with ankylosing spondylitis in clinical practice. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2017;55(4):344-350 (In Russ.). doi: 10.14412/1995-4484-2017-344-350</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics, and outcome. Arthritis Care Res (Hoboken). 2017;69(11):1685-1691. doi: 10.1002/acr.23174</mixed-citation><mixed-citation xml:lang="en">Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics, and outcome. Arthritis Care Res (Hoboken). 2017;69(11):1685-1691. doi: 10.1002/acr.23174</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bibas N, Pignon C, Lopez-Medina C, Gandjbakhch F, Fautrel B, Gossec L. Ultrasonography for the assessment of enthesitis in psoriatic arthritis: Systematic review with meta-analysis. Rheumatology (Oxford). 2025;64(5):2377-2384. doi: 10.1093/rheumatology/keae705</mixed-citation><mixed-citation xml:lang="en">Bibas N, Pignon C, Lopez-Medina C, Gandjbakhch F, Fautrel B, Gossec L. Ultrasonography for the assessment of enthesitis in psoriatic arthritis: Systematic review with meta-analysis. Rheumatology (Oxford). 2025;64(5):2377-2384. doi: 10.1093/rheumatology/keae705</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lin J, Ren Y. Different biologics for biological-naïve patients with psoriatic arthritis: A systematic review and network meta-analysis. Front Pharmacol. 2024;15:1279525. doi: 10.3389/fphar.2024.1279525</mixed-citation><mixed-citation xml:lang="en">Lin J, Ren Y. Different biologics for biological-naïve patients with psoriatic arthritis: A systematic review and network meta-analysis. Front Pharmacol. 2024;15:1279525. doi: 10.3389/fphar.2024.1279525</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mease PJ, Liu M, Rebello S, Hua W, McLean RR, Hur P, et al. Disease characteristics, quality of life, and work productivity by enthesitis site: Real-world data from the US Corrona psoriatic arthritis/spondyloarthritis registry. J Rheumatol. 2021;48(3):367- 375. doi: 10.3899/jrheum.191117</mixed-citation><mixed-citation xml:lang="en">Mease PJ, Liu M, Rebello S, Hua W, McLean RR, Hur P, et al. Disease characteristics, quality of life, and work productivity by enthesitis site: Real-world data from the US Corrona psoriatic arthritis/spondyloarthritis registry. J Rheumatol. 2021;48(3):367- 375. doi: 10.3899/jrheum.191117</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kwok TSH, Sutton M, Pereira D, Cook RJ, Chandran V, Haroon N, et al. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Ann Rheum Dis. 2022;81(12):1678-1684. doi: 10.1136/ard-2022-222537</mixed-citation><mixed-citation xml:lang="en">Kwok TSH, Sutton M, Pereira D, Cook RJ, Chandran V, Haroon N, et al. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Ann Rheum Dis. 2022;81(12):1678-1684. doi: 10.1136/ard-2022-222537</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Grazio S, Šitum M, Grubišić F, Kavanagh HS, Vajdić ID, Krstanović K, et al. Association of enthesitis with severity of psoriasis in psoriatic arthritis: An observational study. Rheumatol Int. 2024;44(12):2891-2896. doi: 10.1007/s00296-024-05730-1</mixed-citation><mixed-citation xml:lang="en">Grazio S, Šitum M, Grubišić F, Kavanagh HS, Vajdić ID, Krstanović K, et al. Association of enthesitis with severity of psoriasis in psoriatic arthritis: An observational study. Rheumatol Int. 2024;44(12):2891-2896. doi: 10.1007/s00296-024-05730-1</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh JA, Ogdie A, Michaud K, Peterson S, Holdsworth EA, Karyekar CS, et al. Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: Findings from a real-world study in the United States and Europe. Joint Bone Spine. 2023;90(3):105534. doi: 10.1016/j.jbspin.2023.105534</mixed-citation><mixed-citation xml:lang="en">Walsh JA, Ogdie A, Michaud K, Peterson S, Holdsworth EA, Karyekar CS, et al. Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: Findings from a real-world study in the United States and Europe. Joint Bone Spine. 2023;90(3):105534. doi: 10.1016/j.jbspin.2023.105534</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Orbai AM, Birt JA, Holdsworth EA, Booth N, Malatestinic WN, Sprabery AT, et al. Impact of enthesitis on psoriatic arthritis patientreported outcomes and physician satisfaction with treatment: Data from a multinational patient and physician survey. Rheumatol Ther. 2020;7(4):937-948. doi: 10.1007/s40744-020-00242-3</mixed-citation><mixed-citation xml:lang="en">Orbai AM, Birt JA, Holdsworth EA, Booth N, Malatestinic WN, Sprabery AT, et al. Impact of enthesitis on psoriatic arthritis patientreported outcomes and physician satisfaction with treatment: Data from a multinational patient and physician survey. Rheumatol Ther. 2020;7(4):937-948. doi: 10.1007/s40744-020-00242-3</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Florescu A, Vere CC, Florescu LM, Mușetescu AE, Bondari A, Ciurea PL. Clinical and ultrasound assessment of enthesis in psoriatic arthritis in a Romanian Cohort. Curr Health Sci J. 2018;44(4):347-351. doi: 10.12865/CHSJ.44.04.04</mixed-citation><mixed-citation xml:lang="en">Florescu A, Vere CC, Florescu LM, Mușetescu AE, Bondari A, Ciurea PL. Clinical and ultrasound assessment of enthesis in psoriatic arthritis in a Romanian Cohort. Curr Health Sci J. 2018;44(4):347-351. doi: 10.12865/CHSJ.44.04.04</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Loginova E, Korotaeva T, Gubar E, Korsakova Y, Glukhova S, Nasonov E, et al. Characteristics of psoriatic arthritis (PsA) patients with enthesitis. Data from Russian PsA registry (RUPSART). Ann Rheum Dis. 2022;81:867.</mixed-citation><mixed-citation xml:lang="en">Loginova E, Korotaeva T, Gubar E, Korsakova Y, Glukhova S, Nasonov E, et al. Characteristics of psoriatic arthritis (PsA) patients with enthesitis. Data from Russian PsA registry (RUPSART). Ann Rheum Dis. 2022;81:867.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Corrao S, Scibetta S, Calvo L, Lo Monaco M, Mallaci Bocchio R, Natoli G, et al. Central obesity in psoriatic arthritis: Associations with disease activity, function, and quality of life in a real-world cohort. Front Med (Lausanne). 2025;12:1684641. doi: 10.3389/fmed.2025.1684641</mixed-citation><mixed-citation xml:lang="en">Corrao S, Scibetta S, Calvo L, Lo Monaco M, Mallaci Bocchio R, Natoli G, et al. Central obesity in psoriatic arthritis: Associations with disease activity, function, and quality of life in a real-world cohort. Front Med (Lausanne). 2025;12:1684641. doi: 10.3389/fmed.2025.1684641</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis. 2015;74(5):813-817. doi: 10.1136/annrheumdis-2013-204448</mixed-citation><mixed-citation xml:lang="en">Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis. 2015;74(5):813-817. doi: 10.1136/annrheumdis-2013-204448</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Leung YY, Eder L, Orbai AM, Coates LC, de Wit M, Smolen JS, et al. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying indexbased and patient-based definitions of remission: A cross-sectional study. RMD Open. 2023;9(3):e003157. doi: 10.1136/rmdopen-2023-003157</mixed-citation><mixed-citation xml:lang="en">Leung YY, Eder L, Orbai AM, Coates LC, de Wit M, Smolen JS, et al. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying indexbased and patient-based definitions of remission: A cross-sectional study. RMD Open. 2023;9(3):e003157. doi: 10.1136/rmdopen-2023-003157</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Haberman RH, Ogdie A, Merola JF, Scher JU, Eder L. The obesity-inflammation axis in psoriatic disease: Mechanisms and therapeutic strategies. Nat Rev Rheumatol. 2026;22(3):151-164. doi: 10.1038/s41584-025-01326-6</mixed-citation><mixed-citation xml:lang="en">Haberman RH, Ogdie A, Merola JF, Scher JU, Eder L. The obesity-inflammation axis in psoriatic disease: Mechanisms and therapeutic strategies. Nat Rev Rheumatol. 2026;22(3):151-164. doi: 10.1038/s41584-025-01326-6</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
